Other Species / Isoforms
  RhoGDI beta (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K4-ac
____MTEkAPEPHVE
0 2
RhoGDI beta (human) ____MTEkAPEPHVE K4-ac
RhoGDI beta (mouse) ____MTEKDAQPQLE K4
RhoGDI beta (rat) ____MTEkDEQPQLE K4-ac
K4-ub
____MTEkAPEPHVE
0 1
RhoGDI beta (human) ____MTEkAPEPHVE K4-ub
RhoGDI beta (mouse) ____MTEKDAQPQLE K4
RhoGDI beta (rat) ____MTEKDEQPQLE K4
D19-ca
EDDDDELdskLNykP
0 1
RhoGDI beta (human) EDDDDELdskLNykP D19-ca
RhoGDI beta (mouse) EEADDDLDsKLNyKP D18
RhoGDI beta (rat) EEGEDELDSkLNYkP D18
S20-p
DDDDELdskLNykPP
1 13
RhoGDI beta (human) DDDDELdskLNykPP S20-p
RhoGDI beta (mouse) EADDDLDsKLNyKPP S19-p
RhoGDI beta (rat) EGEDELDSkLNYkPP S19
K21-ac
DDDELdskLNykPPP
0 4
RhoGDI beta (human) DDDELdskLNykPPP K21-ac
RhoGDI beta (mouse) ADDDLDsKLNyKPPP K20
RhoGDI beta (rat) GEDELDSkLNYkPPP K20-ac
K21-ub
DDDELdskLNykPPP
0 2
RhoGDI beta (human) DDDELdskLNykPPP K21-ub
RhoGDI beta (mouse) ADDDLDsKLNyKPPP K20
RhoGDI beta (rat) GEDELDSKLNYkPPP K20
Y24-p
ELdskLNykPPPQks
Upstream
Downstream
4 338
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell motility, induced
Kinase, in vitro:
  • Abl (human)
  • Src (human)
Putative in vivo kinases:
  • Abl (human)
  • Src (human)
  • Syk (human)
view more >
Treatment
  • siRNA
RhoGDI beta (human) ELdskLNykPPPQks Y24-p
RhoGDI beta (mouse) DLDsKLNyKPPPQKS Y23-p
RhoGDI beta (rat) ELDSkLNYkPPPQkS Y23
K25-ac
LdskLNykPPPQksL
0 3
RhoGDI beta (human) LdskLNykPPPQksL K25-ac
RhoGDI beta (mouse) LDsKLNyKPPPQKSL K24
RhoGDI beta (rat) LDSkLNYkPPPQkSL K24-ac
K25-ub
LdskLNykPPPQksL
0 3
RhoGDI beta (human) LdskLNykPPPQksL K25-ub
RhoGDI beta (mouse) LDsKLNyKPPPQKSL K24
RhoGDI beta (rat) LDSkLNYKPPPQkSL K24
K30-ac
NykPPPQksLkELQE
0 3
RhoGDI beta (human) NykPPPQksLkELQE K30-ac
RhoGDI beta (mouse) NyKPPPQKSLkELQE K29
RhoGDI beta (rat) NYkPPPQkSLkELQE K29-ac
K30-ub
NykPPPQksLkELQE
0 9
RhoGDI beta (human) NykPPPQksLkELQE K30-ub
RhoGDI beta (mouse) NyKPPPQKSLkELQE K29
RhoGDI beta (rat) NYkPPPQKSLkELQE K29
S31-p
ykPPPQksLkELQEM
Upstream
Downstream
2 35
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
Kinase, in vitro:
  • PKCA (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • GF109203X
  • Go_6976
  • phorbol_ester
  • siRNA
view more >
RhoGDI beta (human) ykPPPQksLkELQEM S31-p
RhoGDI beta (mouse) yKPPPQKSLkELQEM S30
RhoGDI beta (rat) YkPPPQkSLkELQEM S30
K33-ac
PPPQksLkELQEMDk
0 3
RhoGDI beta (human) PPPQksLkELQEMDk K33-ac
RhoGDI beta (mouse) PPPQKSLKELQEMDk K32
RhoGDI beta (rat) PPPQkSLkELQEMDk K32-ac
K33-ub
PPPQksLkELQEMDk
0 8
RhoGDI beta (human) PPPQksLkELQEMDk K33-ub
RhoGDI beta (mouse) PPPQKSLkELQEMDk K32-ub
RhoGDI beta (rat) PPPQkSLKELQEMDk K32
K40-ac
kELQEMDkDDEsLIk
0 2
RhoGDI beta (human) kELQEMDkDDEsLIk K40-ac
RhoGDI beta (mouse) kELQEMDKDDESLTK K39
RhoGDI beta (rat) kELQEMDkDDESLTk K39-ac
K40-ub
kELQEMDkDDEsLIk
0 3
RhoGDI beta (human) kELQEMDkDDEsLIk K40-ub
RhoGDI beta (mouse) kELQEMDkDDESLTK K39-ub
RhoGDI beta (rat) kELQEMDKDDESLTk K39
S44-p
EMDkDDEsLIkyKkt
0 2
RhoGDI beta (human) EMDkDDEsLIkyKkt S44-p
RhoGDI beta (mouse) EMDkDDESLTKYKKT S43
RhoGDI beta (rat) EMDkDDESLTkYKKT S43
K47-ac
kDDEsLIkyKktLLG
0 3
RhoGDI beta (human) kDDEsLIkyKktLLG K47-ac
RhoGDI beta (mouse) kDDESLTKYKKTLLG K46
RhoGDI beta (rat) kDDESLTkYKKTLLG K46-ac
K47-ub
kDDEsLIkyKktLLG
0 1
RhoGDI beta (human) kDDEsLIkyKktLLG K47-ub
RhoGDI beta (mouse) kDDESLTKYKKTLLG K46
RhoGDI beta (rat) kDDESLTKYKKTLLG K46
Y48-p
DDEsLIkyKktLLGD
0 126
RhoGDI beta (human) DDEsLIkyKktLLGD Y48-p
RhoGDI beta (mouse) DDESLTKYKKTLLGD Y47
RhoGDI beta (rat) DDESLTkYKKTLLGD Y47
K50-ub
EsLIkyKktLLGDGP
0 18
RhoGDI beta (human) EsLIkyKktLLGDGP K50-ub
RhoGDI beta (mouse) ESLTKYKKTLLGDVP K49
RhoGDI beta (rat) ESLTkYKKTLLGDVP K49
T51-p
sLIkyKktLLGDGPV
0 11
RhoGDI beta (human) sLIkyKktLLGDGPV T51-p
RhoGDI beta (mouse) SLTKYKKTLLGDVPV T50
RhoGDI beta (rat) SLTkYKKTLLGDVPV T50
T60-p
LGDGPVVtDPkAPNV
0 6
RhoGDI beta (human) LGDGPVVtDPkAPNV T60-p
RhoGDI beta (mouse) LGDVPVVADPTVPNV A59
RhoGDI beta (rat) LGDVPVVADPTVPNV A59
K63-ub
GPVVtDPkAPNVVVT
0 16
RhoGDI beta (human) GPVVtDPkAPNVVVT K63-ub
RhoGDI beta (mouse) VPVVADPTVPNVTVT T62
RhoGDI beta (rat) VPVVADPTVPNVTVT T62
K63-ac
GPVVtDPkAPNVVVT
0 1
RhoGDI beta (human) GPVVtDPkAPNVVVT K63-ac
RhoGDI beta (mouse) VPVVADPTVPNVTVT T62
RhoGDI beta (rat) VPVVADPTVPNVTVT T62
S78-p
RLTLVCEsAPGPITM
0 1
RhoGDI beta (human) RLTLVCEsAPGPITM S78-p
RhoGDI beta (mouse) RLSLVCDSAPGPITM S77
RhoGDI beta (rat) RLSLVCDSAPGPITM S77
K95-ac
TGDLEALkkETIVLk
0 5
RhoGDI beta (human) TGDLEALkkETIVLk K95-ac
RhoGDI beta (mouse) TGDLEALKKDtFVLK K94
RhoGDI beta (rat) TGDLKALKkDTFVLK K94
K95-ub
TGDLEALkkETIVLk
0 3
RhoGDI beta (human) TGDLEALkkETIVLk K95-ub
RhoGDI beta (mouse) TGDLEALKKDtFVLK K94
RhoGDI beta (rat) TGDLKALKkDTFVLK K94
K96-ub
GDLEALkkETIVLkE
0 5
RhoGDI beta (human) GDLEALkkETIVLkE K96-ub
RhoGDI beta (mouse) GDLEALKKDtFVLKE K95
RhoGDI beta (rat) GDLKALKKDTFVLKE K95
K96
GDLEALkKETIVLkE
0 1
RhoGDI beta (human) GDLEALkKETIVLkE K96
RhoGDI beta (mouse) GDLEALKKDtFVLKE K95
RhoGDI beta (rat) GDLKALKkDTFVLKE K95-ac
T98
LEALkkETIVLkEGS
0 1
RhoGDI beta (human) LEALkkETIVLkEGS T98
RhoGDI beta (mouse) LEALKKDtFVLKEGI T97-p
RhoGDI beta (rat) LKALKkDTFVLKEGI T97
K102-ac
kkETIVLkEGSEYRV
0 2
RhoGDI beta (human) kkETIVLkEGSEYRV K102-ac
RhoGDI beta (mouse) KKDtFVLKEGIEYRV K101
RhoGDI beta (rat) KkDTFVLKEGIEYRV K101
K102-ub
kkETIVLkEGSEYRV
0 6
RhoGDI beta (human) kkETIVLkEGSEYRV K102-ub
RhoGDI beta (mouse) KKDtFVLKEGIEYRV K101
RhoGDI beta (rat) KkDTFVLKEGIEYRV K101
K110
EGSEYRVKIHFkVNR
0 1
RhoGDI beta (human) EGSEYRVKIHFkVNR K110
RhoGDI beta (mouse) EGIEYRVKINFKVNK K109
RhoGDI beta (rat) EGIEYRVkINFKVNk K109-ac
K114-ub
YRVKIHFkVNRDIVS
0 3
RhoGDI beta (human) YRVKIHFkVNRDIVS K114-ub
RhoGDI beta (mouse) YRVKINFKVNKDIVS K113
RhoGDI beta (rat) YRVkINFKVNkDIVs K113
R117
KIHFkVNRDIVSGLk
0 1
RhoGDI beta (human) KIHFkVNRDIVSGLk R117
RhoGDI beta (mouse) KINFKVNKDIVSGLK K116
RhoGDI beta (rat) kINFKVNkDIVsGLk K116-ac
S121
kVNRDIVSGLkYVQH
0 1
RhoGDI beta (human) kVNRDIVSGLkYVQH S121
RhoGDI beta (mouse) KVNKDIVSGLKYVQH S120
RhoGDI beta (rat) KVNkDIVsGLkYVQQ S120-p
K124-ac
RDIVSGLkYVQHtyR
0 5
RhoGDI beta (human) RDIVSGLkYVQHtyR K124-ac
RhoGDI beta (mouse) KDIVSGLKYVQHTyR K123
RhoGDI beta (rat) kDIVsGLkYVQQTYR K123-ac
K124-ub
RDIVSGLkYVQHtyR
0 11
RhoGDI beta (human) RDIVSGLkYVQHtyR K124-ub
RhoGDI beta (mouse) KDIVSGLKYVQHTyR K123
RhoGDI beta (rat) kDIVsGLKYVQQTYR K123
T129-p
GLkYVQHtyRTGVkV
0 1
RhoGDI beta (human) GLkYVQHtyRTGVkV T129-p
RhoGDI beta (mouse) GLKYVQHTyRTGMRV T128
RhoGDI beta (rat) GLkYVQQTYRNGMkV T128
Y130-p
LkYVQHtyRTGVkVD
Upstream
Downstream
2 33
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell motility, induced
Kinase, in vitro:
  • Abl (human)
Putative in vivo kinases:
  • Abl (human)
Treatment
  • imatinib
  • siRNA
RhoGDI beta (human) LkYVQHtyRTGVkVD Y130-p
RhoGDI beta (mouse) LKYVQHTyRTGMRVD Y129-p
RhoGDI beta (rat) LkYVQQTYRNGMkVD Y129
K135-ub
HtyRTGVkVDkATFM
0 2
RhoGDI beta (human) HtyRTGVkVDkATFM K135-ub
RhoGDI beta (mouse) HTyRTGMRVDkAtFM R134
RhoGDI beta (rat) QTYRNGMKVDkATFM K134
K135-ac
HtyRTGVkVDkATFM
0 2
RhoGDI beta (human) HtyRTGVkVDkATFM K135-ac
RhoGDI beta (mouse) HTyRTGMRVDkAtFM R134
RhoGDI beta (rat) QTYRNGMkVDkATFM K134-ac
K138-ub
RTGVkVDkATFMVGs
0 14
RhoGDI beta (human) RTGVkVDkATFMVGs K138-ub
RhoGDI beta (mouse) RTGMRVDkAtFMVGs K137-ub
RhoGDI beta (rat) RNGMkVDKATFMVGS K137
K138-ac
RTGVkVDkATFMVGs
0 2
RhoGDI beta (human) RTGVkVDkATFMVGs K138-ac
RhoGDI beta (mouse) RTGMRVDKAtFMVGs K137
RhoGDI beta (rat) RNGMkVDkATFMVGS K137-ac
T140
GVkVDkATFMVGsyG
0 1
RhoGDI beta (human) GVkVDkATFMVGsyG T140
RhoGDI beta (mouse) GMRVDkAtFMVGsYG T139-p
RhoGDI beta (rat) GMkVDkATFMVGSYG T139
S145-p
kATFMVGsyGPRPEE
0 4
RhoGDI beta (human) kATFMVGsyGPRPEE S145-p
RhoGDI beta (mouse) kAtFMVGsYGPRPEE S144-p
RhoGDI beta (rat) kATFMVGSYGPRPEE S144
Y146-p
ATFMVGsyGPRPEEy
0 1
RhoGDI beta (human) ATFMVGsyGPRPEEy Y146-p
RhoGDI beta (mouse) AtFMVGsYGPRPEEY Y145
RhoGDI beta (rat) ATFMVGSYGPRPEEY Y145
Y153-p
yGPRPEEyEFLtPVE
Upstream
Downstream
4 24
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell motility, induced
Kinase, in vitro:
  • Src (human)
Putative in vivo kinases:
  • Src (human)
Treatment
  • PP2
  • siRNA
RhoGDI beta (human) yGPRPEEyEFLtPVE Y153-p
RhoGDI beta (mouse) YGPRPEEYEFLTPVE Y152
RhoGDI beta (rat) YGPRPEEYEFLTPVE Y152
T157-p
PEEyEFLtPVEEAPk
0 9
RhoGDI beta (human) PEEyEFLtPVEEAPk T157-p
RhoGDI beta (mouse) PEEYEFLTPVEEAPK T156
RhoGDI beta (rat) PEEYEFLTPVEEAPK T156
K164-ub
tPVEEAPkGMLARGT
0 12
RhoGDI beta (human) tPVEEAPkGMLARGT K164-ub
RhoGDI beta (mouse) TPVEEAPKGMLARGT K163
RhoGDI beta (rat) TPVEEAPKGMLARGT K163
K175-ac
ARGTYHNkSFFtDDD
0 3
RhoGDI beta (human) ARGTYHNkSFFtDDD K175-ac
RhoGDI beta (mouse) ARGTYHNKSFFTDDD K174
RhoGDI beta (rat) ARGTYHNkSFFTDDD K174-ac
K175-ub
ARGTYHNkSFFtDDD
0 2
RhoGDI beta (human) ARGTYHNkSFFtDDD K175-ub
RhoGDI beta (mouse) ARGTYHNKSFFTDDD K174
RhoGDI beta (rat) ARGTYHNKSFFTDDD K174
T179-p
YHNkSFFtDDDKQDH
0 1
RhoGDI beta (human) YHNkSFFtDDDKQDH T179-p
RhoGDI beta (mouse) YHNKSFFTDDDKQDH T178
RhoGDI beta (rat) YHNkSFFTDDDKQDH T178
S194-p
LSWEWNLsIKkEWTE
0 1
RhoGDI beta (human) LSWEWNLsIKkEWTE S194-p
RhoGDI beta (mouse) LTWEWNLAIKKDWTE A193
RhoGDI beta (rat) LTWEWNLAIKKDWTD A193
K197-ac
EWNLsIKkEWTE___
0 1
RhoGDI beta (human) EWNLsIKkEWTE___ K197-ac
RhoGDI beta (mouse) EWNLAIKKDWTE___ K196
RhoGDI beta (rat) EWNLAIKKDWTD___ K196